Propofol - A review of its use in intensive care sedation of adults

被引:146
作者
McKeage, K [1 ]
Perry, CM [1 ]
机构
[1] Adis Int Ltd, Auckland 10, New Zealand
关键词
D O I
10.2165/00023210-200317040-00003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Propofol (Diprivan((R)1)) is a phenolic derivative with sedative and hypnotic properties but is unrelated to other sedative/hypnotic agents. Formulated as an oil-in-water emulsion for intravenous use, it is highly lipophilic and rapidly crosses the blood-brain barrier resulting in a rapid onset of action. Emergence from sedation is also rapid because of a fast redistribution into peripheral tissues and metabolic clearance. The depth of sedation increases in a dose-dependent manner. In well designed clinical trials in patients receiving sedation in the intensive care unit (ICU) for a variety of indications, propofol provided adequate sedation for a similar proportion of time to midazolam, but the rate of recovery was faster with propofol. Even after periods of prolonged sedation (>72 hours), propofol was generally associated with a faster time to recovery than midazolam. Propofol facilitated better predictability of recovery and an improved control of the depth of sedation in response to titration than midazolam. In patients sedated following head trauma, propofol reduced or maintained intracranial pressure. Propofol is associated with generally good haemodynamic stability but induces a dose-dependent decrease in blood pressure and heart rate. Bolus administration may cause transient hypotension, and slow initial infusions are recommended in most patients. Serum triglyceride concentrations should be monitored during prolonged infusions (>3 days) because of the risk of hypertriglyceridaemia. The administration of 2% propofol can reduce this risk. Strict aseptic technique must be used during the handling of the product to prevent accidental extrinsic microbial contamination. Despite a higher acquisition cost with propofol, most studies of short-term sedation (approximately <3 days) showed that overall costs were lower with propofol than with midazolam, because a faster time to extubation reduced total ICU costs. However, as the period of sedation increased, the cost difference decreased.
引用
收藏
页码:235 / 272
页数:38
相关论文
共 174 条
[1]   Effects of propofol containing EDTA on mineral metabolism in medical ICU patients with pulmonary dysfunction [J].
Abraham, E ;
Papadakos, PJ ;
Tharratt, RS ;
Hall, JB ;
Williams, GJ .
INTENSIVE CARE MEDICINE, 2000, 26 (Suppl 3) :S422-S432
[2]   COMPARISON OF PROPOFOL AND MIDAZOLAM FOR SEDATION IN CRITICALLY ILL PATIENTS [J].
AITKENHEAD, AR ;
WILLATTS, SM ;
PARK, GR ;
COLLINS, CH ;
LEDINGHAM, IM ;
PEPPERMAN, ML ;
COATES, PD ;
BODENHAM, AR ;
SMITH, MB ;
WALLACE, PGM .
LANCET, 1989, 2 (8665) :704-709
[3]   PHARMACOKINETICS OF LONG-TERM PROPOFOL INFUSION USED FOR SEDATION IN ICU PATIENTS [J].
ALBANESE, J ;
MARTIN, C ;
LACARELLE, B ;
SAUX, P ;
DURAND, A ;
GOUIN, F .
ANESTHESIOLOGY, 1990, 73 (02) :214-217
[4]   WHY WAS THE URINE GREEN [J].
ANANTHANARAYAN, C ;
FISHER, JA .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1995, 42 (01) :87-88
[5]   Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit [J].
Angelini, G ;
Ketzler, JT ;
Coursin, DB .
CRITICAL CARE CLINICS, 2001, 17 (04) :863-+
[6]   Economic evaluation of propofol for sedation of patients admitted to intensive care units [J].
Anis, AH ;
Wang, XH ;
Leon, H ;
Hall, R .
ANESTHESIOLOGY, 2002, 96 (01) :196-201
[7]  
*ASTR, 2002, DIPR GLOB PRESC INF
[8]   In-use contamination of propofol. A clinical study [J].
Bach, A ;
Motsch, J ;
Schmidt, H ;
Bottiger, BW ;
Bohrer, H ;
Martin, E ;
Sonntag, HG .
EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 1997, 14 (02) :178-183
[9]   PHARMACOKINETICS OF PROPOFOL DURING AND AFTER LONG-TERM CONTINUOUS INFUSION FOR MAINTENANCE OF SEDATION IN ICU PATIENTS [J].
BAILIE, GR ;
COCKSHOTT, ID ;
DOUGLAS, EJ ;
BOWLES, BJM .
BRITISH JOURNAL OF ANAESTHESIA, 1992, 68 (05) :486-491
[10]   PROPOFOL - A NEW DRUG FOR SEDATION IN THE INTENSIVE-CARE UNIT [J].
BARR, J .
INTERNATIONAL ANESTHESIOLOGY CLINICS, 1995, 33 (01) :131-154